Charles River announces success of integrated discovery project with ENYO Pharma
Capture compound mass spectrometry technology enables target identification...
Capture compound mass spectrometry technology enables target identification...
List view / Grid view
Capture compound mass spectrometry technology enables target identification...
Capture compound mass spectrometry technology enables target identification...
Partnership with InSphero provides additional 3D solutions...
Partnership with InSphero provides additional 3D solutions...
Companies to continue collaboration in discovery of next generation anti-malaria…
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
Charles River Laboratories International, Inc. (NYSE: CRL) recently announced updates…
Charles River Laboratories International, Inc. (NYSE: CRL) recently announced updates to its expanding oncology discovery business, including significant additions to its online Tumor Model Compendium...